Our novel approach brings together vital information found through whole-genome sequencing that could help explain your cardiovascular challenges. By combining your genomic information, the most up-to-date scientific literature, and other medical data, we can help your clinicians better treat your unresolved cardiovascular health difficulties.

We provide comprehensive genetic insights that allow us to determine if gene-related reasons may impact your cardiovascular health. We can also assess your polygenic risk scores, which estimates an individual's genetic risk to disease. What this means for you is that the Cardio23 report will, for the first time, give your GP or Specialist information about your cardiovascular disease profile. This can allow them to begin to personalise lifestyle and treatment interventions that suit your genetic profile, which could result in more significant health benefits for you.

We analyse how your genes respond to medications and provide clinicians with the best-suited recommendations to improve their patients' cardiovascular treatment. This precision analysis and reporting allows for more informed discussions and improved outcomes.